Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Psidii Guava's Extract For COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female~* Confirmed positive COVID-19 mild and symptomless~* Aged 13 - 59 years~* Willing to take part in the study and sign an informed consent~Exclusion Criteria:~* Not willing to join the study~* History of allergy to the research drug (extract Psidii guava)

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 59 Years
- Healthy Volunteers: f

Study Arms:
- Extract Psidii guava (Type: EXPERIMENTAL): 2 Capsule of extract Psidii guava, three times daily
- Standard therapy (Type: ACTIVE_COMPARATOR): Standard therapy for Covid-19 patient (vitamin C, Zinc, medication for clinical symptoms such as: antipyretic agent, decongestan and mucolytic.)

Based on this trial design, predict the completion outcome and termination type (if applicable).